GlassScriptPhysician profile
Lisa C Myers
NPI 1598742025
$13,956.20
in general payments reported to CMS, 2019-2025
50 companies · $2,686 in 2025
The $2,686 reported for 2025 was more than what 98% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,024 · 2020: $1,432 · 2021: $1,760 · 2022: $1,920 · 2023: $2,074 · 2024: $2,062 · 2025: $2,686.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,684 · Education: $137.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,684.47 |
| Education | $136.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $1,988.97 | 2019-2025 | Ozempic, Rybelsus, Wegovy |
| Astrazeneca Pharmaceuticals LP | $1,808.49 | 2019-2025 | Airsupra, Farxiga, Breztri |
| Glaxosmithkline, LLC. | $1,149.05 | 2019-2025 | Trelegy Ellipta, Shingrix, Arexvy |
| Janssen Pharmaceuticals, INC | $1,085.31 | 2019-2025 | Xarelto, Spravato |
| Abbvie INC. | $995.97 | 2021-2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $993.38 | 2019-2025 | Jardiance, Synjardy |
| Lilly USA, LLC | $890.67 | 2019-2025 | Mounjaro, Zepbound, Jardiance |
| Bayer Healthcare Pharmaceuticals INC. | $851.79 | 2021-2025 | |
| Pfizer INC. | $616.67 | 2019-2025 | |
| Dexcom, INC. | $385.14 | 2021-2025 | Dexcom G6 Transmitter |
| Takeda Pharmaceuticals U.S.A., INC. | $325.48 | 2019-2025 | Trintellix |
| Merck Sharp & Dohme LLC | $323.39 | 2019-2025 | Gardasil 9, Vaxelis, Vaxneuvance |
| Amgen INC. | $222.58 | 2019-2025 | Otezla, Repatha, Otezla |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $198.12 | 2021-2025 | Xifaxan, Trulance |
| Amarin Pharma, INC. | $171.52 | 2019-2021 |
Show all 50 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| E.R. Squibb & Sons, L.L.C. | $151.76 | 2019-2025 | Eliquis |
| Biohaven Pharmaceuticals, INC. | $149.10 | 2020-2021 | |
| Teva Pharmaceuticals USA, INC. | $142.99 | 2021-2024 | Austedo Xr |
| Daiichi Sankyo INC. | $120.05 | 2021-2024 | Injectafer |
| Abbott Laboratories | $117.14 | 2021-2025 | Freestyle Libre 3, Freestyle Libre |
| Sanofi Pasteur INC. | $104.99 | 2019-2024 | |
| Exact Sciences Corporation | $104.14 | 2023-2025 | Cologuard Collection Kit, The Cologuard Plus Collection Kit |
| Alnylam Pharmaceuticals INC. | $100.72 | 2025 | Amvuttra |
| Janssen Biotech, INC. | $99.95 | 2025 | Erleada |
| Bridgebio Pharma, INC. | $82.66 | 2025 | Attruby |
| Sanofi-Aventis U.S. LLC | $67.15 | 2019-2021 | |
| Xeris Pharmaceuticals, INC. | $65.68 | 2022-2023 | Gvoke Hypopen |
| Otsuka America Pharmaceutical, INC. | $58.13 | 2025 | Rexulti |
| Biohaven Pharmaceutical Holding Company LTD. | $51.89 | 2022 | |
| Allergan, INC. | $46.73 | 2019-2020 | |
| Scpharmaceuticals INC. | $45.99 | 2024-2025 | |
| American Regent | $40.80 | 2024 | Injectafer |
| Viatris Specialty LLC | $39.40 | 2025 | Yupelri |
| Medtronic, INC. | $33.52 | 2025 | Inceptiv |
| Philips North America LLC | $31.93 | 2024 | (Ak6) Vest Therapy |
| Cequr Corporation | $31.37 | 2024 | Cequr Simplicity |
| Seqirus USA INC | $28.53 | 2025 | Flucelvax, Fluad |
| Astellas Pharma US INC | $28.12 | 2019-2021 | |
| Smith+Nephew, INC. | $26.42 | 2022 | |
| Boston Scientific Corporation | $21.37 | 2022 | |
| Sunovion Pharmaceuticals INC. | $20.83 | 2019 | |
| Inspire Medical Systems, INC. | $19.98 | 2024 | Inspire |
| Bausch Health US, LLC | $19.73 | 2021 | |
| Phathom Pharmaceuticals, INC. | $18.22 | 2025 | Voquezna |
| Corcept Therapeutics | $16.85 | 2025 | Korlym |
| Mylan Specialty L.P. | $14.46 | 2019 | |
| Novartis Pharmaceuticals Corporation | $13.78 | 2022 | |
| Kyowa Kirin, INC. | $13.59 | 2025 | |
| Hologic Sales and Service, LLC | $11.70 | 2022 | |
| Bardy Diagnostics, INC. | $10.00 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lisa Myers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.